News in brief: Cancer of Unknown Primary trial problems; Radiotherapy underused in metastatic disease; Cancer patient vaccine responses

Radiotherapy utilisation suboptimal for metastatic disease patients Radiotherapy uptake is suboptimal for patients with metastatic cancer on diagnosis (MCOD), despite its known benefits in improving overall survival and quality, an Australian study has found. A review of records for 2392 patients with MCOD showed that radiotherapy utilisation rate was 32.3%, significantly lower than the optimal rate ...

Already a member?

Login to keep reading.

© 2021 the limbic